Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia

Clinical Cancer Research

Volumn 4, Issue 1, 1998, Pages 69-73

  Riccardi, Riccardo ^a   Riccardi, Anna ^a   Lasorella, Anna ^a   Servidei, Tiziana ^a   Mastrangelo, Stefano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RADIATION DOSE; SKULL IRRADIATION; STATISTICAL ANALYSIS;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; CYTARABINE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; MALE;

EID: 0031907498     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Riehm, H., Freickert, H. J., and Lampert, F. Acute lymphoblastic leukemia. In: P. A. Voute, A. Barrett, H. J. G. Bloom, J. Lemerle, and M. R. Neidhart (eds.). Cancer in Children, Ed. 2, pp. 85-106. Berlin: Springer-Verlag, 1992.
2. Bleyer, A. CNS chemoradiotherapy of childhood leukemia: the plot thickens but the ending bodes well. J. Clin. Oncol., 13: 2480-2482, 1995.
3. Creutzig, U., Ritter, J., Zimmermann, M., and Schellong, G. Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the childhood acute myelogenous leukemia study BFM-87. J. Clin. Oncol., 11: 279-286, 1993.
4. Aur, R. J. A., Simone, J., Hustu, H. O., Walters, T., Borrella, L., Pratt, C., and Pinkel, D. Central nervous system therapy and combination chemotherapy of childhood ALL. Blood, 37: 271-281, 1971.
5. Mulhern, R., Fairclough, D., and Ochs, J. Prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J. Clin. Oncol., 9: 1348-1356, 1991.
6. Niemeyer, C. M., Reiter, A., Riehm, H., Donnelly, M., Gelber, R. D., and Sallan, S. E. Comparative results of two intensive treatment programs of childhood acute lymphoblastic leukemia: the Berlin-Frankfurt-Munster and Dana-Farber Cancer Institute protocols. Ann. Oncol., 2: 745-749, 1991.
7. Price, R. A., and Jamieson, P. A. The central nervous system in childhood leukemia. II. Subacute encephalopathy. Cancer (Phila.), 35: 306-318, 1975.
8. Riehm, H., Gadner, H., Henze, G., Konrhuber, B., Lampert, F., Niethammer, D., Reiter, A., and Schellong, G. Results and significance of six randomized trials in four consecutive ALL BFM studies. Haematol. Blood Transfus., 33: 439-450, 1990.
9. Creutzig, U., Ritter, J., Riehm, H., Langermann, H. J., Henze, G., Kabisch, H., Niethammer, D., Jurgens, H., Stolmann, B., Lasson, U., Kaufmann, U., Loffler, H., and Shellong, G. Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood, 65: 298-304, 1985.
10. De Angelis, L., Kreis, W., Chan, K., Dantis, E., and Akerman, S. Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of 1-β-D-arabinofuranosylcytosine. Cancer Chemother. Pharmacol., 29: 173-177, 1992.
11. Riccardi, A., Servidei, T., Lasorella, A., and Riccardi, R. High-performance liquid chromatographic assay for 1-β-D-arabinofuranosylcytosine and uracil arabinoside in cerebrospinal fluid and plasma. J. Chromatogr., 497: 302-307, 1989.
12. Altman, D. G. Practical Statistics for Medical Research, pp. 205-213. London: Chapman and Hall, Ltd., 1990.
13. Vassal, G. Bases pharmacologiques de la chimiothérapie des tumeurs cèrèbrales de l'enfant. Bull. Cancer, 77: 699-713, 1990.
14. Van Prooijen, H. C., Muus, P., and Roelofs, J. Does the metabolites uracil arabinoside inhibit citosine arabinoside (ara-C) penetration into the cerebrospinal fluid during high-dose ara-C therapy? Scand. J. Haematol., 36: 123-126, 1986.
15. Lundqvist, H., Rosander, K., Lomanov, M., Lukjashin, V., Shimchuk, G., Zolotov, V., and Minakova, E. Permeability of the blood-brain barrier in the rat after local proton irradiation. Acta Radiol. Oncol., 21: 267-271, 1982.
16. Pitcock, J. A. An electron microscopic study of acute radiation injury of the rat brain. Lab. Invest., 11: 1-6, 1962.
17. Remler, M. P., and Marcussen, W. H. Time course of early delayed blood-brain barrier changes in individual cats after ionizing radiation. Exp. Neurol., 73: 310-314, 1981.
18. Griffin, T. W., Rasey, J. S., and Bleyer, W. A. The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer (Phila.), 40: 1109-1113, 1977.
19. Levin, V. A., Landhal, H. T. D., and Freeman-Dove, M. A. The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier. J. Pharmacokinet. Biopharm., 4: 499-519, 1976.
20. Kamen, B. A., Moulder, J. E., Kun, L. E., Ring, B. J., Adams, S. M., Fish, B. L., and Holcenberg, J. S. Effects pf single-dose and fractionated cranial irradiation on rat brain accumulation of methotrexate. Cancer Res., 44: 5092-5094, 1984.
21. Qin, D. X., Zheng, R., Tang, J., Li, J. X., and Hu, Y. H. Influence of radiation on the blood-brain barrier and optimum time of chemotherapy. Int. J. Radiat. Oncol. Biol. Phys., 19: 1507-1510, 1990.
22. Stephani, U., Rating, D., Korinthenberg, R., Siemes, H., Riehm, H., and Hanefeld, F. Radiation-related disturbance of blood/brain barrier during therapy of acute lymphoblastic leukemia. Lancet, 2: 1036-1037, 1983.
23. Korinthenberg, R., Ullrich, K., Ritter, J., and Stephani, U. Electrolytes, amino acids and proteins in lumbar CSF during the treatment of acute leukemia in childhood. Acta Paediatr. Scand., 79: 335-342, 1990.
24. Seshandri, R. S., Ryall, R. G., Rice, M. S., Leahy, M., and Ellis, R. The effect of cranial irradiation on blood-brain barrier permeability to methotrexate. Aust. Paediatr. J., 15: 184-186, 1979.
25. Riccardi, R., Lasorella, A., Tartaglia, R. L., Riccardi, A., Servidei, T., and Mastrangelo, R. Cranial irradiation and cerebrospinal and fluid levels of 6-mercaptopurine in children with acute leukemia. Med. Pediatr. Tumor Pharmacother., 8: 95-98, 1991.
26. Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., and Bertino, J. R. Multidrug-resistance gene (p-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA, 86: 695-698, 1989.
27. Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., Berns, A. J. M., and Borst, P. Disruption of the mouse mdr1a p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77: 491-502, 1994.